Tigris Pharmaceuticals, Inc.

Bonita Springs, FL 34134

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $1.49MM
First Award Date 08/15/07
Most Recent Award Date 09/01/08

Key Personnel

Last Name Name Awards Contact
Nguyen Binh Nguyen 3

3 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-47
Budget: 09/01/08 - 08/31/09

DESCRIPTION (provided by applicant): 4,4'-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) was originally developed as an immune modulator of immune deficiency associated cancerous growths. In a recent study, A-007 was administered as a topical gel to treat anogenital cancers associated with the human papillomavirus (HPV). There were no...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-47
Budget: 09/20/07 - 08/31/08

DESCRIPTION (provided by applicant): 4,4'-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) was originally developed as an immune modulator of immune deficiency associated cancerous growths. In a recent study, A-007 was administered as a topical gel to treat anogenital cancers associated with the human papillomavirus (HPV). There were no...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-47
Budget: 08/15/07 - 08/31/07

DESCRIPTION (provided by applicant): 4,4'-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) was originally developed as an immune modulator of immune deficiency associated cancerous growths. In a recent study, A-007 was administered as a topical gel to treat anogenital cancers associated with the human papillomavirus (HPV). There were no...